The company will use the new funds to complete development of its first set of products and fund initial FDA 510(k) clinical studies. Its first product is Cue Health Monitoring System, a connected diagnostic platform.
Johnson & Johnson Innovation-JJDC, Section 32, Dentsu Ventures, Synergy Ventures, Principles of Tarsadia Investments, Pritzker Group Venture Capital, Babel Ventures and Troy Capital were all new investors in the financing round.
More articles on health IT:
Healthcare organizations hit hardest by breach costs
16 hospitals, health systems seeking Allscripts, Cerner, Epic, Meditech talent
KLAS: 13 precision medicine vendors with high ‘mindshare’ among providers
